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The use of pluripotent stem cells in regenerative
medicine and disease modeling is complicated by
the variation in differentiation properties between
lines. In this study, we characterized 13 human
embryonic stem cell (hESC) and 26 human induced
pluripotent stem cell (hiPSC) lines to identify markers
that predict neural differentiation behavior. At
a general level, markers previously known to distin-
guish mouse ESCs from epiblast stem cells (EPI-
SCs) correlated with neural differentiation behavior.
More specifically, quantitative analysis of miR-371-3
expression prospectively identified hESC and hiPSC
lines with differential neurogenic differentiation
propensity and in vivo dopamine neuron engraftment
potential. Transient KLF4 transduction increased
miR-371-3 expression and altered neurogenic
behavior and pluripotency marker expression.
Conversely, suppression of miR-371-3 expression in
KLF4-transduced cells rescued neural differentiation
propensity. miR-371-3 expression level therefore
appears to have both a predictive and a functional
role in determining human pluripotent stem cell
neurogenic differentiation behavior.
INTRODUCTION
Human pluripotent stem cells (hPSCs) represent a powerful and
potentially unlimited source for disease modeling and for
applications in regenerative medicine. Although multiple proto-
cols have been developed to derive specific cell types in vitro,
there is considerable variability in the efficiency of generating
differentiated lineages among independent hESC and hiPSC
lines (Osafune et al., 2008; Tavakoli et al., 2009). Currently there
is no method available that predicts a priori the differentiation
properties of a given cell line. Therefore, extensive optimizationof individual lines is required to obtain comparable results across
lines. Such variability is particularly problematic for the use of
patient-specific iPSC lines in disease modeling because it can
mask disease-related phenotypes. A number of recent studies
suggested that hiPSC lines display an even greater level of vari-
ability than hESCs concerning the derivation of neural cell types
(Hu et al., 2010) or hemangioblastic lineages (Feng et al., 2010).
Multiple factors may contribute to the specific differences
observed among hiPSC lines such as partial reprogramming,
incomplete silencing of transgenes, or genemisregulation result-
ing from insertional mutagenesis. The reasons for the variability
among hESC lines cannot be readily ascribed to such technical
arguments and remain largely unexplored.
Studies in the mouse have identified two distinct pluripotent
states that can be captured in vitro. Classic mouse ESC cultures
are derived from the preimplantation embryo whereas mouse
epiblast-stem cells are derived from the epiblast stage of post-
implantation embryos (Tesar et al., 2007; Brons et al., 2007). In
addition to their distinct morphologies, mouse ESCs and EPI-
SCs exhibit differential requirements with regard to LIF/BMP
versus FGF/Activin signaling and differential marker expression
(Tesar et al., 2007; Brons et al., 2007). The specific signaling
requirement and marker expression in hESCs suggest that
human cells more closely reflect the properties of mouse EPI-
SCs rather than mouse ESCs. Very recently, two independent
studies reported the induction of mouse ESC-like populations
from hESCs upon exposure to specific genetic (Hanna et al.,
2010) or extrinsic (Xu et al., 2010) stimuli. Although these studies
all raise interesting questions about the reversibility of a given
pluripotent state, they do not address the nature of differences
among existing pluripotent cell lines. The identification of
prospectivemarkers would be a first step in exploring themolec-
ular mechanisms responsible for cell line-specific differences
and offer a practical strategy to select appropriate lines for trans-
lational applications.
In the current study, we characterized the pluripotent behavior
of more than 30 independent hPSC lines and identified a set of
markers that correlate with in vitro differentiation behavior.
Many of the differentially expressed markers represent genes
previously shown to distinguish mouse ESCs versus EPI-SCs.Cell Stem Cell 8, 695–706, June 3, 2011 ª2011 Elsevier Inc. 695
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Predicting Differentiation Propensity in hPSCsWe further demonstrate that miR-371-3 levels in undifferentiated
hPSCs can be used to predict in vitro neural differentiation
behavior of a given cell line. Finally, we report that transient over-
expression of KLF4 is capable of altering differentiation behavior
and pluripotent marker expression. Our findings indicate that the
variable differentiation propensity among hPSC lines is in part
due to differences in pluripotent state and offer a simple strategy
to predict and manipulate cell line properties.
RESULTS
Markers that Correlate with Neural Differentiation
Propensity Are Related to EPI-SC State
Multiple protocols are available to direct hPSCs toward the
neural lineage including stromal feeder-based protocols such
as MS5 (Perrier et al., 2004), embryoid-body based protocols
(Zhang et al., 2001), and defined neural induction protocols
(dual SMAD-inhibition protocol) (Chambers et al., 2009). When
comparing the differentiation behavior of multiple independent
hESC lines, we observed considerable variability in neural yield
in all protocols tested. The derivation of Pax6+ neuroepithelial
precursors was particularly efficient in some hESC lines such
as I6 while comparatively inefficient in other lines such as
HUES6 (Figures 1A–1C). In a first effort to identify potential
molecular markers that correlate with the neural differentiation
response, we monitored global mRNA and miRNA expression
via microarray analysis in four hESC lines in triplicate (H9, I4,
I6, HUES6). All lines were subjected to FACS-mediated enrich-
ment for SSEA4 prior to analysis to eliminate cells undergoing
spontaneous differentiation from the analysis. We systematically
compared mRNA and miRNA expression data for each of the
four lines with the corresponding data from the other lines to
identify cell lines most distinct each other based purely on global
expression data. At the undifferentiated state, the highly neuro-
genic I6 line showed the most striking differences in gene
expression as compared to the other lines with upregulation of
transcripts previously reported to mark mouse EPI-SCs versus
mouse ESCs including FOXA2, EOMES, CER1, and DKK1 (Fig-
ure 1D). At the miRNA level, HUES6 was the hESC line most
distinct from the other three lines with significant upregulation
of the miR-371-3 (Figure 1E), corresponding to the miR-290
cluster in mice. Differential expression of miR-371-3 was partic-
ularly intriguing, because there was some suggestion that
expression of the miR-290 cluster may mark cells in the ICM of
the mouse blastocyst and mouse ESCs but not EPI-SC stage
cells (Tang et al., 2010; Tesar et al., 2007). We tested both
primary mouse EPI-SCs, kindly provided by P. Tesar (Tesar
et al., 2007), and EPI-SCs generated from mouse ESCs via
in vitro differentiation (Zhang et al., 2010). Both types of EPI-
SCs showed significantly lower levels of expression of the
miR-290 cluster and higher levels of miR-302 cluster (Figures
S1F and S1G available online).
Quantitative expression analysis of a subset of the markers by
qRT-PCR further confirmed the microarray data (Figure S1A).
Transcripts that distinguish ESCs from EPI-SCs in the mouse
and which showed significant differential expression among
the four hESC lines tested here faithfully segregated across lines,
with I6 showing the most EPI-SC-like gene expression and with
HUES6 at the other end of the spectrum (Figure 1F). There were696 Cell Stem Cell 8, 695–706, June 3, 2011 ª2011 Elsevier Inc.no obvious differences in growth behavior or in any other basic
parameters of pluripotency, and all the lines displayed a normal
karyotype (Figures S1B–S1D). Furthermore, clonogenic poten-
tial was also comparable between I6 and other commonly
used hESC lines such as H9 (Figure S1E), further supporting
the notion that I6 exhibits robust self-renewal properties in vitro.
Validation in a Large Set of hESC and hiPSC Lines
Our initial analysis was limited to a small selection of hESC lines
based on their in vitro characteristics and neural differentiation
propensity. Therefore it was essential to validate any potential
markers of pluripotent state in a larger set of hESC lines and to
test whether marker expression and in vitro behavior correlate
in a similar manner in hiPSC lines. We analyzed a set of 33
hPSC lines (23 hiPSC lines and 10 hESC lines) (Table S1). In addi-
tion to markers of EPI-SC (FOXA2, EOMES) versus ESC (ZFP42,
miR-371-3) state (Figure 2A), we also quantified expression of
surface markers that have been previously proposed to mark
hESCs at various states of pluripotency (Figure 2B; Stewart
et al., 2006; Draper et al., 2002; Enver et al., 2005). Clustering
of the data from 33 hPSC lines tested showed a strong segrega-
tion of lines according to the levels of mir-371-3 expression.
Clustering of the surface marker expression profile showed a
partial correlation of mir-371-3 expression with the levels of cells
expressing SSEA3 and TRA-1-60 (Figure 2B). We next analyzed
the data for absolute levels and variability in marker expression
among hESC (n = 10) versus the variability among hiPSC (n =
23) lines. Recent studies suggested that hiPSC lines show a
greater degree of variability with regard to differentiation into
specific cell types (Hu et al., 2010; Feng et al., 2010). Here, we
observed a slightly higher percentage of cells positive for surface
marker associated with pluripotency in hiPSC versus hESC lines,
and mean expression of mir-371-3 and ZFP42 were significantly
higher in hiPSC lines (Figures 2C–2E). Although hiPSC lines were
in average of slightly lower passage numbers (Table S1), there
was no significant correlation of EPI-SC (FOXA2, EOMES) versus
ESC (ZFP42, miR-371-3) state with regard to passage number
across all hPSC lines tested. Furthermore, for several markers,
hiPSC lines showed significantly less variability in expression
as compared to hESC lines including SSEA4, TRA-1-60,
ZFP42, and FOXA2 (Figures 2C–2E; Figure S2A), suggesting
that hiPSC lines may behavemore similar with regard to markers
of pluripotent state. All hiPSC lines were fully pluripotent and
capable of teratoma formation (Figure S2B; Papapetrou et al.,
2009, 2011; Maherali et al., 2007; Soldner et al., 2009). Another
potential confounding factor that could impact variability of
marker expression in hiPSC lines is incomplete transgene
silencing of the reprogramming factors. To this end we analyzed
three additional hiPSC lines from two different sources (Soldner
et al., 2009; Papapetrou et al., 2011) that were confirmed
transgene-free. Those lines showed comparable variability in
marker expression though relatively low levels of miR-371-3
expression (Figure S2C). To further address this question, we
measured residual transgene expression in the 20 hiPSC lines
created via the four color vector system allowing real-time
tracking of the expression of each of the four reprogramming
factors (Papapetrou et al., 2009). We observed that there was
no correlation of residual transgene levels and marker expres-
sion among hiPSC lines with the exception of incomplete KLF4
Figure 1. Neural Induction and Differential Marker Expression in hESC Lines
(A) Representative images of OCT4 and PAX6 immunocytochemistry after MS5-mediated neural induction (Perrier et al., 2004) at P0 d15 (top) and PAX6
expression at d11 of the dual-SMAD inhibition protocol (Chambers et al., 2009) (bottom) in four different hESC lines. Scale bars represent 50 mm.
(B) PAX6 mRNA levels at P0 d15 of MS5-mediated neural induction measured by qRT-PCR and expressed as fold changes compared to the levels in undif-
ferentiated hESCs (n = 4).
(C) PAX6 mRNA levels at day 6 of the dual-SMAD inhibition protocol. Values were normalized to GAPDH expression and converted to log2 value (n = 3).
(D and E) mRNA and miRNAmicroarray data were obtained in undifferentiated, SSEA4+ sorted hESCs (I6, I4, H9, and HUES6 line). Data analysis was performed
comparing data from all the lines against each other to define expression profiles that best discriminate among lines.
(D) Transcriptome analysis (IlluminaWG-6, n = 3 for each line). The I6 lines showed themost distinct mRNA expression pattern among the four lines with increased
levels of FOXA2 and decreased levels of ZFP42 as compared to the three other lines. HUES6 was selectively depleted for FOXA2 and DKK1 as compared to the
three other lines.
(E) miRNA expression (Agilent, n = 3 for each line). HUES6 showed the most distinct miRNA expression pattern. The top significantly increased and decreased
mRNAs and miRNAs are presented according to the corresponding Venn diagrams.
(F) Normalized expression data in the four hESC lines based on the microarray results (n = 3) for human transcripts that correspond to the genes previously
reported to distinguish mEPI-SCs (light shade) from mESCs (dark shade). Error bars indicate ±SEM (*p < 0.05; ***p < 0.001).
See also Figure S1.
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Predicting Differentiation Propensity in hPSCssilencing that showed an association with increased miR-371-3
levels (Figure S2D).
Predicting Neural Differentiation Behavior Based on
mir-371-3 Expression
Our data from 33 hPSC lines suggest that specific markers ex-
pressed at the pluripotent stage, such asmiR-371-3, are nonran-domly distributed. Such markers could be useful as a tool to
a priori predict the differentiation behavior of a given line. To
find candidate markers that might best predict neural differenti-
ation propensity, we performed a retrospective analysis
correlating marker expression in a subset of 15 lines (10 hiPSC
and 5 hESC lines) (Table S1) with neural induction propensity
as measured by the levels of PAX6 transcript at day 15 ofCell Stem Cell 8, 695–706, June 3, 2011 ª2011 Elsevier Inc. 697
Figure 2. Marker Expression and Variability among 33 hPSC Lines
(A and B) Analysis of mRNA, miRNA, and pluripotent surface marker expression in 33 hPSC lines. The names of the hESC (unlike hiPSC) lines are highlighted
in green.
(A) Clustering of qRT-PCR data for mRNA (FOXA2, EOMES, ZFP42) and miRNA-371-3 expression.
(B) Clustering of FACS data for surface marker (SSEA3, SSEA4, TRA-1-60) expression among hPSC lines.
(C–E) Quantitative comparisons of the expression levels for surface markers, miRNAs, and mRNAs in hESC (n = 10) versus hiPSC (n = 23) lines. p values indicate
significance of the differences in mean expression between hESC and hiPSC lines. Variability in marker expression was expressed as median absolute deviation
(m.a.d.; see Figure S2A) revealing significantly decreased values for m.a.d. in hiPSC versus hESC lines for the following markers: ZFP42 (p < 0.01); FOXA2
(p < 0.01); TRA-1-60 (p < 0.01); SSEA4 (p < 0.001).
See also Figure S2.
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Predicting Differentiation Propensity in hPSCsMS5-mediated neural differentiation (Perrier et al., 2004). There
was a negative correlation of miR-371 and miR-373 and the
propensity of a given cell lines to express PAX6 (Figure S3A).
Maintenance of OCT4 expression upon neural differentiation
showed the opposite trend (Figure S3B). To test the hypothesis
that the levels of miR-371-3 expression at the undifferentiated
stage can predict neural differentiation propensity, we prospec-
tively selected a subset of hESC and hiPSC lines based solely on
differential levels of miR-371-3 expression (Figure S3C). Each of
the 12 prospectively selected lines (Table S1) was again differen-
tiated toward neural lineage via the MS5 protocol. Analysis of
PAX6 expression at d15 of differentiation confirmed a striking
negative correlation with miR-371-3 (Figure 3A). In contrast,
OCT4 expression was negatively correlated with miR-371 and
miR-372 (Figure S3D). To further corroborate our findings and
to extend our hypothesis to an alternative neural differentiation
approach, we tested an second set of 14 prospectively identified
cell lines (see Table S1) and differentiated each of those lines via
the dual-SMAD-inhibition protocol (Chambers et al., 2009). We
observed a highly significant correlation of miR-371-3 and
PAX6 expression in this second prospectively identified set of
cell lines when differentiated in the presence of Noggin or
Noggin/SB431542 (Figure 3B; Figure S3E). In the presence of
SB431542 only, we observed a significant negative correlation
of PAX6 with miR-372 and miR-373, whereas the correlation698 Cell Stem Cell 8, 695–706, June 3, 2011 ª2011 Elsevier Inc.with miR-371 did not reach statistical significance under this
condition. We next performed immunocytochemical analysis
for PAX6 and NESTIN confirming neural differentiation propensi-
ties in miR-371-3lo versus miR-371-3hi hPSC lines at the protein
level (Figure 3C). A systematic correlation matrix of all parame-
ters tested identified additional correlations including a negative
correlation between miR-371-3 expression and markers of
EPI-SC state such as FOXA2 and EOMES (Figure 3D). We also
provide correlations for those additional markers with PAX6
expression after neural induction (marked PAX6* in Figure 3D).
Those additional correlations are, however, retrospective in
nature and based on the data sets derived from the lines
selected based on miR-371-3 levels. In female hESC lines (n =
7), we tested in addition whether there is a correlation of XIST
mRNA and neural differentiation propensity. Although xist regu-
lation in mouse ESCs is tightly coupled with pluripotency and
X-inactivation status (Navarro et al., 2008), XIST levels in hESCs
are thought to be a less reliable marker of X-inactivation (Silva
et al., 2008; Tchieu et al., 2010). We did not observe a significant
correlation between XIST and PAX6 expression (Figure S3F).
In order to further validate our hypothesis, we tried to find
data in the literature that would challenge the model regarding
miR-371-3 levels and neural differentiation propensity. For
example, the relatively low neurogenic propensity of HUES6
(with associated high miR-371-3 levels) could be considered
Figure 3. Predicting Neural Differentiation
Propensity in Prospectively Selected hPSC
Lines Based on miR-371-3 Expression
Levels
(A and B) The levels of miR-371-3 at undifferenti-
ated stage correlated inversely with the levels of
PAX6 upon differentiation toward neural lineage
with both MS5 protocol (A) or feeder-free dual
SMAD-inhibition protocol (B) in prospectively
selected hPSC lines (**p < 0.01). Data for each
hPSC line are derived from three independent
differentiations (n = 3). For details on selection
criteria, see Figure S3C and Table S1.
(C) PAX6 and NESTIN expression in miR-371-3lo
and miR-371-3hi lines with two hESC and two
hiPSC lines in each group. The cell lines with low
miR-371-3 (I6, H9, 2C1, K6) showed more PAX6
and NESTIN expression compared to those with
high miR-371-3 lines (HUES6, H7, 2C10, K8).
Scale bar represents 50 mm.
(D) Correlation matrix for marker expression and
neural differentiation behavior among 12 hPSC
lines (n = 3). Data were obtained from qRT-PCR
(mRNAs and miRNAs) or FACS analysis (surface
marker) at undifferentiated stage. However,
PAX6* indicates the level of PAX6 mRNA upon
MS5-mediated neural differentiation (compare to
A). Green box indicates significant positive
correlation (p < 0.05) of two markers meeting at
crossing; red box indicates significant negative
correlation (p < 0.05); and white box indicates no
significant correlation.
See also Figure S3.
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HUES6 among the HUES lines with relatively high neurogenic
propensity. To address this apparent discrepancy, we
measured miR-371-3 levels in a subset of HUES lines with
high versus low neurogenic propensity according to the pub-
lished data (Osafune et al., 2008). Remarkably, miR-371-3
profiling correctly predicted the neurogenic propensity data in
those lines (Figure S3G). These data demonstrate that
HUES10 and HUES13 have increased miR-371-3 expression
levels even when compared to the rather high levels observed
in HUES6.
Selecting hESC and Disease-Specific iPSC Lines for
Dopamine Neuron Differentiation and Engraftment
Predicting neural differentiation potential could be of obvious
use in selecting hESC or hiPSC lines for applications in neuralCell Stem Cell 8, 695–disease modeling or cell repair. In a first
effort to address this hypothesis, we
selected two hESC lines and two hiPSC
lines purely based on differential miR-
371-3 expression levels and tested their
efficacy for differentiation toward neural
lineages and their ability to yield differen-
tiated progeny suitable for use in
disease-relevant transplantation assays.
In the case of hiPSC lines, we used two
clones of hiPSCs generated from theidentical same fibroblast source, a patient with sporadic Parkin-
son’s disease. PD-iPSC clones were generated upon lentiviral
transduction with vectors expressing the classic Yamanaka
factors, each linked to unique color through a P2A element (Pa-
papetrou et al., 2009).
Initial differentiation studies in the two hESC lines (I6:
miR-371-3lo versus HUES6: miR-371-3hi) showed that
differences in neural induction efficiency also translated into
differences in the expression of midbrain dopaminergic
(DA) neuron markers after further neural patterning and
differentiation (Figures 4A–4C). With our previously published
protocol (Perrier et al., 2004), based on SHH/FGF8-mediated
patterning of purified neural rosettes, we observed increased
levels of midbrain DA neuron marker expression in the I6
line as compared to HUES6 line. However, both lines were
capable of inducing midbrain DA neuron markers with the706, June 3, 2011 ª2011 Elsevier Inc. 699
Figure 4. Predicting Dopamine Neuron Differentiation and Engraftment Potential of Prospectively Selected hPSC Lines
(A) Immunocytochemistry for EN1 and PAX2 at P2 d7 and EN1, TH, and TUJ1 in P3 cultures in HUES6 and I6, two representative lines for miR-371-3hi and
miR-371-3lo state.
(B) Only the I6 line showed significant expression of FOXA2 and colabeling of FOXA2 with TH and EN1.
(C) Differential expression level of representative markers by qRT-PCR (EN1, PAX2, LMX1A, LMX1B, FOXA2, TH) for DA differentiation at P2 d7 and P2 d14 time
points. Values are expressed as fold changes over the values detected in undifferentiated hESCs (n = 4).
(D) Quantification of the cells positive for EN1+/TH+ and TH+/TUJ1+ in P3 cultures (n = 3–5 independent experiments; 10 fields each/replicate).
(E) Morphology of transplanted hESC- and hiPSC-derived TH+ cells at 6 weeks postgrafting and immunohistochemistry for human nuclear antigen (hNA), TUJ1,
TH, and FOXA2 in the grafts.
(F) Quantification of the number of TH+ cells and graft size via unbiased stereological techniques in hESC lines (n = 5).
(G) Quantification of the number of TH+ cells and graft size in hiPSC line (n = 3).
Error bars indicate mean ± SEM (*p < 0.05; **p < 0.01; ***p < 0.001). Scale bars represent 50 mm. See also Figure S4.
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midbrain DA neurons (Kittappa et al., 2007), which was in-
duced robustly only in the I6 line (Figures 4B and 4C). Although
the final in vitro percentages of neurons positive for the
dopamine neuron marker tyrosine hydroxylase (TH) were
only slightly different between I6 and HUES6 lines (Figure 4D),
transplantation of DA neuron precursors in vivo showed
a dramatic difference in the total TH+ cell numbers and TH+
neuron density within grafts 6 weeks after transplantation
(Figures 4E–4G). The significant difference in dopamine neuron
survival (Figure 4F, right) was confirmed in a second fully
blinded study with the same two hESC lines (I6 versus
HUES6; Figure S4A) and in the two PD-iPSC lines selected
(Figure 4E, bottom, and Figure 4G, right). In the case of the
PD-iPSC, randomly selected 2C10 line (miR-371-3hi) showed
very low numbers of PAX6+ precursors at the neural induction
stage (Figure S4B) and did not yield an engraftable DA neuron
precursor population, whereas the miR-371-3lo 2C1 line
exhibited robust TH+ neuron survival in vivo at numbers higher
than those obtained from HUES6 (mir-371-3hi) hESC line
(Figures 4F and 4G).700 Cell Stem Cell 8, 695–706, June 3, 2011 ª2011 Elsevier Inc.Dependence on BMP Inhibition Distinguishes Lines with
Low versus High Neurogenic Propensity
Our data suggest that prescreening hPSC lines for miR-371-3
expression may be a useful strategy to select cell lines for
directed differentiation assays. However, these data do not
address whether miR-371-3 is simply a marker of the pluripotent
state or functionally involved in determining neural differentiation
propensity. We have recently described a dual SMAD-inhibition
protocol to achieve highly efficient neural differentiation in
hPSC lines (Chambers et al., 2009). Here we tested whether
differences in efficiency of neural induction among different cell
lines can be linked to differential requirements for inhibiting
BMP versus TGF-b/Activin/Nodal signaling. We selected six
lines based on miR-371-3 expression levels (miR-371-3hi lines:
H7, HUES6, 2C10; miR-371-3lo lines: H9, I6, 2C1). Differentiation
in the presence of Noggin and SB431542 resulted in neural
differentiation of both miR-371-3hi and miR-371-3lo cell lines
based on PAX6 induction and suppression of trophectodermal
marker CDX2 (Figures 5A and 5B). In contrast, differentiation in
the presence of SB431542 alone in the absence of extrinsic
BMP inhibitors resulted in neural differentiation in miR-371-3lo
Figure 5. The Levels of miR-371-3 Expres-
sion Are Correlated with Differential
Requirements for BMP Inhibition during
Neural Induction
(A and B) The levels of PAX6 (A) and CDX2 (B) by
qRT-PCR at d6 upon exposure to different SMAD
inhibition condition in two groups of miR-371-3hi
and miR-371-3lo cell lines (miR-371-3hi lines: H7,
HUES6, 2C10; miR-371-3lo lines: H9, I6, 2C1).
(C and D) Gain or loss of function for miR-371-3
does not affect neural differentiation potential.
(C) The levels of PAX6 at d6 of neural induction
after dual-SMAD inhibition protocol in miR-371-3
mimic-transfected I6 cells (left) and miR-371-3
antagomir-transfected HUES6 cells (right).
(D) The levels of PAX6 at d6 in cells exposed to
various SMAD inhibition condition after miR-371-3
or GFP control lentiviral transduction of I6 line (D).
Data represent mean ± SEM (***p < 0.001). See
also Figure S5.
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the presence of BMP4, known to suppress neural differentiation,
miR-371-3lo cell lines showed significant induction of PAX6
(Figure 5A). Differentiation of miR-371-3hi lines in the presence
of SB431542 yieldedCDX2-expressing cells while supplementa-
tion with BMP4 was required to induce CDX2 in miR-371-3lo cell
lines (Figure 5B).
Our results demonstrate that miR-371-3 expression identifies
pluripotent cell lines with differential requirements for BMP
inhibition during neural induction. Preliminary data comparing
phospho-SMAD1/5/8 levels in I6 versus HUES6 cells by intracel-
lular FACS analysis showed high levels of BMP pathway activa-
tion in both lines at the undifferentiated state and upon induction
of differentiation via SB431542 (Figure S5A). To test whether
miR-371-3 levels are functionally involved in regulating BMP
signaling in hESCs and modulating neural induction, we per-
formed gain- and loss-of-function studies with mimics and anta-
gomirs for miR-371-3.We first tested the function of bothmimics
and antagomirs by using a dual luciferase assay with constructs
containing multiple miR-371-3 binding sites (Figure S5B). Trans-
fection of the I6 (miR-371-3lo) line with mimics for miR-371-3 did
not yield significant differences in neural induction efficiency
upon exposure to Noggin/SB431542 compared to control
mimics, though there was a trend toward decreased PAX6 levels
(Figure 5C, left). Introduction of antagomirs against miR-371-3 in
HUES6 (miR-371-3hi) line did not significantly affect the levels of
PAX6 during differentiation (Figure 5C, right). To more conclu-
sively address the impact of miR-371-3 overexpression, we
repeated the studies by using lentiviral miR-371-3 expressionCell Stem Cell 8, 695–(Figures S5C–S5E) but again did not
observe a significant change in PAX6
levels upon differentiation (Figure 5D).
Exposure to miR-371-3 antagomirs
induced a reduction in ID1 and ID2 (Fig-
ure S5F). ID1 and ID2 are direct transcrip-
tional target genes of BMP signaling in
ESCs (Hollnagel et al., 1999). These data
indicate that exposure tomiR-371-3 anta-gomirs causes a decrease in BMP signaling possibly via dere-
pression of a BMP inhibitory molecule. Gain-of-function studies
with mimics or lentiviral vectors for miR-371-3 did not signifi-
cantly affect ID1 or ID2 (Figures S5F and S5G). The lack of a clear
impact on neural differentiation suggests that miR-371-3hi
versus miR-371-3lo hPSC lines may have undergone additional
changes that impact BMP responsiveness. Alternatively, miR-
371-3-mediated regulation of BMP signaling (supported by the
ID1, ID2 data) is too weak to impact neural differentiation under
those conditions. Finally, our data suggest that inhibiting BMP
signaling pharmacologically may partly compensate for cell
line-specific differences during neural differentiation.
Transient Expression of KLF4 Converts hESCs from
miR371lo to miR-371-3hi State with Reduced Neural
Differentiation Propensity
Studies in the mouse have demonstrated that mouse EPI-SCs
can be converted into cells with mouse ESC features under
several settings such as long-term culture in mouse ESC culture
medium (Bao et al., 2009) or combinations of changes in culture
condition and introduction of transcription factors such as
Nanog and KLF4 (Hanna et al., 2009). KLF4 appears to be
most effective at converting mouse EPI-SCs into mouse ESCs
and very recent work indicates that a similar transition may be
achievable in hESCs after transgene expression under selective
culture conditions (Hanna et al., 2010). We next tested whether
the differential behavior among hESC lines can be modulated
by overexpression of KLF4. To this end a total of five hESC lines
were selected based on miR-371-3 expression and transduced706, June 3, 2011 ª2011 Elsevier Inc. 701
Figure 6. Transient KLF4 Expression Converts hESC Marker Expression and Neural Differentiation Behavior
Experimental scheme for KLF4 overexpression studies via a P2A-based lentiviral vector system (A) (Papapetrou et al., 2009): KLF4-transduced hESCs were
purified by FACS based on mCherry-KLF4 expression and compared to control transduced hESCs purified based on mCherry-control expression (B, C). For
neural differentiation studies (D, E), KLF4- or control transduced I6 cells, FACS purified for mCherry-KLF4 and mCherry-control, respectively, were cultured for
one additional week followed by a second FACS step isolating both positive and negative (silenced) populations. Silenced populations of I6 line for both KLF4 and
control transduced cells were used for neural differentiation assays (transient KLF4 expression).
(B) Expression of miR-371-3 in HUES6 and I6 lines after KLF4 transduction (n = 3).
(C) qRT-PCR quantification for selective markers in HUES6, I6, and I4 lines after KLF4 versus control transductions (n = 3).
(D) Levels of PAX6 and CDX2 at d6 after various SMAD inhibition conditions in KLF4 silenced versus control silenced I6 cells (n = 3) (n.d., not detected).
(E) Lentiviral overexpression of miR-371-3 versus GFP control in KLF4-transduced I6 cells induces altered neural differentiation behavior (n = 3). See also
Figure S6E presenting data onmiR-371-3 mimics and antagomirs resulting similarly in significant regulation of neural differentiation behavior in KLF4-transduced
cells.
Error bars indicate ±SEM (*p < 0.05; **p < 0.01; ***p < 0.001). See also Figure S6.
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via P2A element or control mCherry lentiviral vectors. After trans-
duction of mCherry-KLF4 versus mCherry-control vector, cells
were purified via FACS for the coexpression of mCherry and
SSEA4 and assessed formarkers of pluripotent state (Figure 6A).
Interestingly, KLF4-transduced cells changed their marker
profile from miR-371-3lo to miR-371-3hi status with a dramatic
increase in the expression of ZFP42 and miR-371-3 and
a decrease in XIST expression (Figures 6B and 6C; Figure S6A).
By contrast, expression of the miR-302 cluster expressed highly
in pluripotent cells was not significantly affected after KLF4702 Cell Stem Cell 8, 695–706, June 3, 2011 ª2011 Elsevier Inc.transduction (Figure S6B). To address whether transient expres-
sion of KLF4 is sufficient to shift pluripotent state and neural
differentiation propensity, we purified cells for mCherry-KLF4
versus mCherry-control expression followed by an additional
week of in vitro culture and a second round of FACS for cells
that have silenced transgene after the initial sort (Figure 6A:
KLF4silenced versus mCherrysilenced fraction). Analysis of marker
expression confirmed that transient KLF4 expression is sufficient
to convert cells toward a miR-371-3hi expression profile at levels
comparable to the cells that have not undergone transgene
silencing (Figures S6C and S6D). In addition to the shift in marker
Figure 7. A Model for Defining and Modulating Human Pluripotent
States and Predicting Neural Differentiation Propensity
(A) Schematic illustration of mRNA, miRNA, and surface marker expression in
hPSCs that are shared such as OCT4 and NANOG versus those that may
distinguish different pluripotent states. Representative markers that are
associated with a more naive pluripotent state include SSEA3 and TRA-1-60,
while FOXA2 and EOMES show an inverse pattern. Expression of miR-371-3
and ZFP42, two other markers associated with a more naive pluripotent state,
are shown to be induced by KLF4 in miR-371lo (i.e., primed) hESCs such as I6.
See also Figure S7 for impact of butyrate on miR-371-3 and other markers of
naive pluripotent state.
(B) Schematic illustration of the interaction of KLF4 transduction and modu-
lation of miR-371-3 expression on neural differentiation. The functional impact
of miR-371-3 expression on neural differentiation remains unclear under
control conditions. However, upon KLF4 transduction of miR-371lo (i.e.,
primed) hESCs, miR-371-3 is shown to repress neural differentiation. We
postulate that KLF4 induces additional factors involved in neural suppression
and in mediating competence to miR-371-3 signal.
(C) Illustration of the inverse correlation of miR-371-3 expression at undiffer-
entiated stage and the efficiency of neural differentiation. Quantification of
miR-371-3 levels enables prediction of the neural differentiation propensity of
individual hPSC lines.
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decreased neural induction propensity as compared to
mCherrysilenced fraction, matching the behavior of miR-371-3hi
cells (Figure 6D).Functional Role for miR-371-3 on Neural Differentiation
in KLF4-Transduced hESCs
Our results demonstrate that transient expression of KLF4 is
sufficient to switch marker expression and neural differentiation
behavior in hESC lines toward amiR-371-3hi phenotype.We next
asked whether the increased miR-371-3 expression after KLF4
transduction is functionally responsible for the change in neural
differentiation propensity. To this end, the I6 (miR-371-3lo) line
was transduced with KLF4 and control vectors after the sameparadigm as above (Figure 6A). However, in this case the
KLF4silenced and mCherrysilenced fraction were further exposed
to miR-371-3 versus control antagomirs and mimics and subse-
quently tested for their neural differentiation potential (Fig-
ure S6E). Treatment with miR-371-3 mimics decreased while
treatment with miR-371-3 antagomirs increased neural differen-
tiation efficiency in KLF-transduced I6 cells. The miR-371-3
gain-of-function data in KLF4-transduced hESCs were
confirmed with lentiviral miR-371 overexpression (Figure 6E).
The rescue observed in miR-371-3 antagomir-treated cells
suggests that increased miR-371-3 expression after transient
KLF4 expression is a major contributor to the decreased neural
differentiation propensity. There was a more pronounced effect
of miR-371-3 inhibition on the neural differentiation of cell lines
induced tomiR-371-3hi status via KLF4 transduction (Figure S6E)
compared to the studies in cell lines that are intrinsically
miR-371-3hi (independent of KLF4 transduction; Figure 5).
This suggests that miR-371-3 expression is not the only factor
affecting neural differentiation behavior in intrinsically miR-
371-3hi cell lines and that other currently unknown factors must
contribute to this response.
Our data showed a higher variability in marker expression and
neural differentiation behavior among hESC than hiPSC lines
(Figures 2C–2E). Because the variability among hESC lines
was related to differences in pluripotent state, we performed
a preliminary study to test whether such variability can be
reduced upon KLF4 transduction in a set of five independent
hESC lines (Figures S6F and S6G). In conclusion, our data
confirm that KLF4 transduction alters pluripotent cell line
behavior toward a miR-371-3hi status based on marker expres-
sion (Figure 7A). We also report that KLF4 impairs neurogenic
propensity of miR-371-3lo hESC lines. Gain- and loss-of-function
studies with miR-371-3 showed an impact on neural differentia-
tion but only in KLF4-transduced cells. Therefore we speculate
that KLF4 may induce additional factor(s) critical for manifesta-
tion of the functional relationship between miR-371-3 and neural
differentiation (Figure 7B). However, independent of any poten-
tial functional relationship, the key finding of our study is that
miR-371-3 levels can be used to reliably predict cell line-specific
neural differentiation propensities (Figure 7C).DISCUSSION
Several previous studies explored differences among hESC lines
in marker expression and differentiation behavior (Osafune et al.,
2008). However, past work was unable to discover prospective
markers that reliably predict the behavior of a given cell lines
prior to differentiation. The identification of predictive markers
in the current study may have been facilitated by the use of
directed differentiation assays as compared to the embryoid
body assays used previously (Osafune et al., 2008) and the large
set of 39 independent hPSC lines analyzed in our study. Finally,
we includedmiRNA profiling as part of our analysis leading to the
identification of the miR-371-3 cluster as a key discriminating
factor. The fact that our findings could be reproduced in multiple
independent hPSC lines, across multiples passages, suggests
that pluripotent states are a relatively stable property of a given
line. In addition, we were able to reproduce these data for twoCell Stem Cell 8, 695–706, June 3, 2011 ª2011 Elsevier Inc. 703
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robustness of our finding.
The key practical application of our findings is the use of
miR-371-3 profiling to select hPSC lines with high versus low
neurogenic propensity. Our data suggest that such differences
are robust and not limited to the early PAX6 lineage. In fact, we
find similar differences in the propensity to generate engraftable
midbrain dopamine neurons. Our data on the differential in vivo
performance were robust as the initial grafting study, comparing
DA neurons from I6 versus HUES6, was confirmed in a second,
blinded, and fully independent grafting study with those same
two lines (Figure S4A). The third independent in vivo study with
PD-iPSC lines from the same fibroblast donor but from clones
belonging to the miR-371-3hi versus miR-371-3lo group further
supportedour findings.However,we testedonly a relatively small
number of hPSC lines in vivo and future studieswill be required to
further validate our results. Another concern for such transplanta-
tion studies is the ability to clearly distinguish between poor
in vitro versus poor in vivo performance, because low neural
differentiation potential in vitro can impact the number of engraft-
able neuron precursors. Interestingly, the Cyno-1 line, a monkey
parthenogenetic line previously shown to yield engraftable
authentic midbrain DA neurons at very high efficiencies (San-
chez-Pernaute et al., 2008), also displayed amiR-371-3lo marker
profile comparable to the profile of I6 (Figure S4C). Despite the
reproducible nature of the results, we are currently unable to
pinpoint the mechanism underlying differential in vivo perfor-
mance of DA neuron cultures from miR-371-3hi versus miR-
371-3lo cell lines. One interesting hypothesis is a potential role
for FOXA2. We observed higher levels of FOXA2 in the I6 (miR-
371-3lo) line both at the undifferentiated stage and upon DA
neuron differentiation. FOXA2 is a critical factor for DA neuron
survival in mouse models in vivo (Kittappa et al., 2007). The
midbrain floor plate has been shown to give rise to the midbrain
DA neuron lineage during mouse development in vivo (Kittappa
et al., 2007; Ono et al., 2007). Furthermore, we have recently
reported FOXA2 induction as a limiting factor in inducing hESC-
derived midbrain floor plate precursors (Fasano et al., 2010).
The classic midbrain DA neuron protocol used in the current
study (Perrier et al., 2004) is suboptimal for inducing FOXA2
expression. Therefore, if FOXA2 is a limiting factor in the deriva-
tion of midbrain DA neurons, hPSC lines with a propensity to
induce FOXA2 may yield midbrain dopamine neurons more
readily. Alternatively, the more robust neurogenic propensity of
miR-371-3lo lines may lead to a more synchronized response to
midbrain patterning cues as yet another possible explanation
for the increased yield in engraftable midbrain DA neurons.
It is currently unclear whether the variations in marker expres-
sion and differentiation propensity reflect a distinct develop-
mental origin of the lines or are due to an in vitro selection
process. It is tempting to speculate that such changes reflect
an ESC- versus EPI-SC-like behavior reminiscent of the changes
described for pluripotent cell lines from the pre- versus early
postimplantation embryo. However, preliminary studies suggest
that miR-371hi hESC lines are not LIF responsive and do not
survive under conventional mouse ESC culture conditions
(data not shown). The recent reports on converting hESC or
hiPSC lines to amore naive pluripotent state with growth proper-
ties similar to mouse ESCs (Hanna et al., 2010; Xu et al., 2010;704 Cell Stem Cell 8, 695–706, June 3, 2011 ª2011 Elsevier Inc.Buecker et al., 2010), offer a novel strategy to manipulate plurip-
otent states. In contrast, our data deal with the existing variability
in hESC or hiPSC lines and offer a simple strategy to predict
neurogenic propensity prior to differentiation. However, our
KLF4 transduction results are compatible with at least a partial
shift of miR-371-3lo hESCs toward amore naive pluripotent state
based onmarker expression such asmiR-371-3 and ZFP42 (Fig-
ure 7A). Another published report suggests acquisition of more
naive pluripotent properties in hESCs after exposure to butyrate
(Ware et al., 2009). With our assay we observed that butyrate
exposure indeed induces expression of miR-371-3 in hESC lines
but does not affect any other markers such as ZFP42 or XIST
(Figure S7A).
At the mechanistic level, our data point to a differential
response in BMP signaling among cell lines that is in part related
to the varying levels of miR-371-3 expression. An important
question is the identification of putative BMP inhibitors targeted
directly or indirectly by miR-371-3. Several candidate molecules
with BMP inhibitor activities and miR-371-3 binding sites are
expressed in hESCs such as BAMBI, CHRD, and CRIM1.
Although the differential response to BMP signaling was
confirmed across multiple lines, similar studies with 12 modula-
tors of developmental signaling in I6 versus HUES6 line did not
reveal any other obvious differences (Figure S7B). This suggests
a remarkable specificity for the link between BMP responsive-
ness and cell line variability. In a recent study in the mouse
(Zhang et al., 2010), a role for BMP signaling has been described
at the transition from the mouse ESC to an EPI-SC-like state. It is
interesting to speculate whether the stronger requirement for
BMP inhibition in miR-371-3hi hESC lines may be related to the
need to overcome this early role for BMPs at the FGF/ERK-
dependent transition to an EPI-SC state.
In conclusion, our study offers a systematic approach to
define heterogeneity in marker expression and neural differenti-
ation behavior across hESC and hiPSC lines. We identify
markers at the pluripotent state that are predictive of cell line
behavior. Differential BMP responsiveness may explain the
need for extensive optimization of differentiation protocols
among individual cell lines and offers a strategy to deal with
such variability. Finally our study should enable the selection of
cell lines most suitable for future translational applications and
presents a novel entry point to define the molecular mechanism
underlying human pluripotent states.
EXPERIMENTAL PROCEDURES
hPSC Culture and Neural Differentiation
13 hESC lines and 26 hiPSC lines were used for this study as detailed in Table
S1. hPSC lines were maintained on mitotically inactivated MEFs. PD-hiPSCs
lines were generated from fibroblasts of a sporadic PD patient (Coriell,
AG20442) as described previously (Papapetrou et al., 2009). For single cell
clonal analysis, hESCs were dissociated with accutase and replated on MEF
at 500–2000 cells/cm2 in the presence of Y-27632 (Tocris). For neural differen-
tiation, hPSCs were induced with either MS5-coculture (Perrier et al., 2004;
Lee et al., 2010) or dual-SMAD inhibition (Chambers et al., 2009) protocols
and further differentiated toward DA neuron lineage (Perrier et al., 2004).
Gene Expression Profiling and Functional Studies
Global mRNA and miRNA analysis was performed with Illumina bead arrays
(Human ref-8) and Agilent miRNA platforms. Data were analyzed with the
LIMMA package from Bioconductor (http://www.bioconductor.org). For
Cell Stem Cell
Predicting Differentiation Propensity in hPSCsmRNA and miRNA qRT-PCR, samples were amplified with Taqman (Applied
Biosystems), Quantitect SYBR, or miScript (QIAGEN) assays. KLF4 overex-
pression studies were performed with lentiviral vectors coexpressing mCherry
via P2A element (Papapetrou et al., 2009). For gain and loss of function of
miR-371-3, hESCs were transfected with 50 nM of mimics or 25 nM modified
(Kru¨tzfeldt et al., 2007) antagomirs (both Dharmacon) for miR-371-3 and
control, respectively, and harvested for luciferase GloMax (Promega) and
neural differentiation studies. For lentiviral overexpression the miR-371-3
cluster was PCR amplified from genomic DNA and cloned into the AB.G.
vector system (Papapetrou et al., 2010).
Transplantation Studies and Stereological Analysis of Grafts
All animal experiments were done in accordance with protocols approved by
our Institutional Animal Care and Use Committee and according to NIH guide-
lines for animal welfare. DA neuron precursors at day 6–8 of P1 culture were
dissociated and cells negative for both SSEA4 (R&D Systems) and Forse1
(DSHB) were isolated by FACS (MoFlo, Dako) and transplanted (200,000 cells
in 1 ml) into the intact striatum of adult SCID Beige mice (Charles River). At
6 weeks after transplantation, brains were processed for cryosectioning and
immunohistochemical analysis. The number of TH+ neurons and graft volume
were quantified by stereological analysis. Teratoma assays were performed by
intramuscular injection of hPSCs (106 cells/mouse) into NOD-SCID-IL2-g-null
mice.
Flow Cytometry and Immunocytochemistry
Flow cytometry (FACS Calibur from Becton Dickinson) was performed for
characterizing pluripotent hPSC state (SSEA3, TRA-1-60, SSEA1, SSEA4,
OCT4) and for monitoring BMP signaling (phospho-SMAD-1/5/8). For immu-
nocytochemical analyses, cells were fixed in 4% paraformaldehyde and
stained for the primary and appropriate secondary antibodies detailed in
Supplemental Experimental Procedures.
Statistical Analysis
Values are from at least three independent experiments with multiple repli-
cates each and reported as mean ± SEM. Comparisons among groups were
performed either by one-way ANOVA followed by Newman-Keuls test or by
t test and Wilcoxon test for pair-wise comparisons. Correlation analysis was
performed with the Pearson’s test. For variance in marker expression between
hESC lines versus hiPSC lines, we used the Ansari-Bradley test for detecting
differences in scale (‘‘R’’ statistical software).
ACCESSION NUMBERS
The microarray data are available in the Gene Expression Omnibus (GEO)
database (http://www.ncbi.nlm.nih.gov/gds) under the accession number
GSE27834.
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